首頁 › 非小細胞肺癌 › 德克薩斯州 › Sugar Land
Sugar Land, TX 的 非小細胞肺癌 臨床試驗
8 項針對 非小細胞肺癌 的研究正在 Sugar Land（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Houston Methodist Sugar Land Hospital, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Kelsey-Seybold Clinic - Fort Bend Campus, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
招募中1/2 期
- Voyage Clinical, Sugar Land
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- USO - Texas Oncology Gulf Coast, Sugar Land
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
招募中2 期
- MD Anderson, Sugar Land
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Sugar Land 的其他研究
- 肥胖症11 項研究
- 過重10 項研究
- 過度嗜睡症7 項研究
- 乳癌7 項研究
- 異位性皮膚炎（濕疹）6 項研究
- 脂肪性肝病6 項研究
- 肺癌6 項研究
- 第二型糖尿病5 項研究
- 睡眠障礙5 項研究
- 肺炎鏈球菌感染4 項研究
- 嗜睡症4 項研究
- 轉移性癌症4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。